Literature DB >> 11599520

Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.

R N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11599520      PMCID： PMC88444          DOI： 10.1128/JCM.39.10.3810-3811.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  10 in total

1.  Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D E Low; N Keller; A Barth; R N Jones
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

2.  Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.

Authors:  A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

3.  Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  M P Weinstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  Treatment of skin and soft tissue infections with imipenem/cilastatin.

Authors:  R J Fass; E H Freimer; R V McCloskey
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

Review 5.  Review of the in vitro spectrum of activity of imipenem.

Authors:  R N Jones
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

Review 6.  Pathogenesis and treatment of endocarditis.

Authors:  H Donabedian; E H Freimer
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965

Review 7.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

8.  Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.

Authors:  D L Shungu; A T Cerami; E Weinberg; T Capizzi; H H Gadebusch
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Imipenem/cilastatin therapy of bacteremia.

Authors:  L J Eron
Journal:  Am J Med       Date:  1985-06-07       Impact factor: 4.965
  10 in total
  1 in total

1.  Endophthalmitis caused by Enterococcus mundtii.

Authors:  Tomomi Higashide; Mami Takahashi; Akira Kobayashi; Shinji Ohkubo; Mayumi Sakurai; Yutaka Shirao; Toshihiro Tamura; Kazuhisa Sugiyama
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.